Table 3 Diarrhea-associated events
Peptamen® AF (n = 46) | Isosource® Energy (n = 44) | Treatment effect | p value | |||
|---|---|---|---|---|---|---|
n | n (%) with event | n | n (%) with event | Risk ratio (95% CI) | ||
Patients that experienced diarrhea during their ICU stay | 45 | 29 (64%) | 44 | 31 (70%) | 0.91 (0.68–1.22) | 0.65 |
Patients receiving a fecal collector during their ICU stay | 45 | 23 (51%) | 44 | 24 (55%) | 0.94 (0.63–1.39) | 0.83 |
n | No. of events (pd) | n | No. of events (pd) | Rate ratio (95% CI) | ||
Days with interruption of EN due to diarrhea | 46 | 0 (253 pd) | 44 | 2 (287 pd) | nd | 0.28 |
n | Median (IQR) | n | Median (IQR) | Median difference a (95% CI) | ||
Total costs of diarrhea per patient/day, CHF | 45 | 3.66 (0.00–8.73) | 44 | 2.60 (0.00–6.39) | 0.00 (−0.36 to 2.70) | 0.35 |
Nurse workload per patient/day, min | 45 | 17.0 (0.0–38.5) | 44 | 13.1 (0.0–21.5) | 2.5 (−0.7 to 11.8) | 0.28 |